Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Colorectal Neoplasms 10Breast Neoplasms 10Prostatic Neoplasms 9Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Multiple Myeloma 3Lymphoma 3Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Malignant Solid Neoplasm 2Lung Neoplasms 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hematopoietic and Lymphoid System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Prostate Cancer Patients 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 7Cisplatin 7Surgical Procedures, Operative 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Platinum 3Chemoradiotherapy 3Cetuximab 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3Radiotherapy 2Radiation 2Interviews as Topic 2Docetaxel 2toripalimab 1sacituzumab govitecan 1merphos 1ipatasertib 1cabozantinib 1X-Rays 1Tretinoin 1Surveys and Questionnaires 1Standard of Care 1Radiotherapy, Image-Guided 1Radiosurgery 1Practice Guidelines as Topic 1Nivolumab 1Neoadjuvant Therapy 1Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Hypopharyngeal Neoplasms × Interviews as Topic × Clear all
NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Mayo Clinic

Phase 2 Recruiting
25 enrolled
Head & Neck

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡